Illumina just purchased Pacific BioSciences (PacBio) for $1.2 billion. Shawn Baker formerly worked for Illumina as both a scientist and manager. He currently serves as the chief science officer for AllSeq and as a genomics startup advisor and consultant at GEN asked Shawn about the significance of Illumina buying PacBio to the sequencing market and to obtain his take on what’s driving the Illumina deal?

Previous articleMutation Helps Abnormal Blood Stem Cells Stage Post-Chemo Comeback
Next articleRare Genetic Disorder Research Opens Door to Novel Melanoma Therapy